Moderna is hiking the price of its COVID-19 shot because it faces "increased complexity and risk" as the pandemic stabilizes and the life-saving vaccine pivots from a government-funded product to a commercial one, CEO Stephane Bancel told Congress Wednesday in a Senate hearing on what taxpayers are owed after they support critical medicine.
